This diabetes drug is a leading treatment for obesity in the United States

He US pharmaceutical market As such is experiencing a revolution with the inclusion of weight loss drugs Ozempic, Wagowie, expensive And Zapbound. These drugs, which belong to the class of drugs GLP-1It has been shown to have a significant effect on reducing body weight and improving health in overweight or obese people. The notoriety of these treatments has grown rapidlyBoth because of the positive results on patients’ health and because of concerns about its misuse for aesthetic purposes.

This GLP-1 inhibitors They work by regulating blood sugar and sending satiety signals to the brain, helping patients reduce their calorie intake. According to experts, these treatments have proven effective not only in weight control, but also in reducing cardiovascular risk and controlling diabetes. Diabetes. However, demand has increased, with patients paying 1,200 dollars per month for treatment.

“This is a great scientific breakthrough, not just because of it Weight controlBut Cardiovascular risk reduction and diabetes treatment. People are getting well, and that is the goal of medicine. It’s not just about being thin,” said for CBS News Dr. Rekha Kumar, Chief Physician of foundA weight loss application used by patients to seek and receive medical care Ozempic.

The interest in these drugs has also extended to the field of health, attracting attention as well Wall Street for its market potential. Analyst Simon Siegel Pointed out in an interview with the same medium, the possibility that Success of GLP-1 drugs If its use becomes widespread, the impact will be on fields ranging from sports to fashion to airlines.

However, concerns about side effects and lack of data Long term effect They remain topics of debate among experts. “One of the active research questions currently being conducted around this class of drug is, What happens when you stop taking it? “We believe that people tend to gain the weight back,” he said. Dr. my gordonAssistant Professor at Cooper Medical School No Rowan University.

On the other hand, Dr. Gordon, who considers himself a “body-positive doctor,” said he is concerned about the impact of using these drugs in relation to stigma: “The problem is fatphobia. The problem is a culture that discriminates against people based on their body size. “It’s a really serious moral problem facing our civilization and Ozempic is a perfect part of it.”

Ozempic It is a medicine whose active ingredient is SemaglutideAnd although it is primarily designed for treatment Type 2 diabetesIt has gained attention for its side effects associated with weight loss.

Active ingredient of OzempicSemaglutide mimics the action of glucagon-like peptide 1 (GLP-1), a natural hormone that regulates appetite and food intake. By activating receptors GLP-1, Ozempic Promotes overproduction of insulin in response to elevated blood sugar levels, while inhibiting the release of glucagon, a hormone that raises blood sugar levels.

In addition, the drug can slow gastric emptying, which helps people Feeling full for a long time after eatingThus reducing the amount of food consumed and potentially contributing to weight loss.

It needs to be mentioned Ozempic It is not approved as a specific drug for weight loss, its use should only be considered under strict medical guidance, as its main indication is the management of type 2 diabetes. Any consideration Ozempic For weight loss, potential adverse effects and the patient’s health profile must be considered. Instead, it should be integrated into a weight management plan that includes diet, exercise, and lifestyle changes.